background
outbreak
enteroviru
respiratori
infect
children
report
global
japan
outbreak
autumn
septemberoctob
aim
studi
compar
polymeras
chain
reaction
pcr
posit
pcrneg
patient
method
pediatr
patient
admit
respiratori
symptom
septemb
octob
enrol
nasopharyng
swab
test
multiplex
respiratori
viru
pcr
revers
transcriptionpcr
pcrposit
neg
patient
compar
regard
demograph
data
clinic
inform
result
nasopharyng
swab
obtain
patient
admit
respiratori
symptom
studi
period
detect
sampl
median
age
pcrposit
neg
group
year
iqr
year
year
iqr
year
respect
rate
coinfect
two
group
respect
signific
differ
histori
asthma
recurr
wheez
length
hospit
pediatr
intens
care
unit
admiss
rate
group
median
day
symptom
onset
admiss
significantli
lower
group
day
vs
day
p
identifi
clade
b
phylogenet
analysi
case
acut
flaccid
myeliti
encount
conclus
half
sampl
children
admit
respiratori
symptom
posit
pcr
outbreak
asthma
histori
associ
risk
develop
sever
respiratori
infect
japan
sever
case
detect
respiratori
sampl
report
annual
sinc
except
number
case
increas
dramat
respect
drew
global
attent
huge
outbreak
respiratori
infect
report
usa
case
confirm
august
decemb
infect
mostli
occur
children
present
cough
wheez
without
histori
asthma
reactiv
airway
diseas
patient
hospit
usa
requir
intens
care
receiv
mechan
ventil
support
becam
worldwid
epidem
total
case
report
countri
although
nine
case
report
japan
year
concurr
cluster
acut
flaccid
myeliti
without
evid
infect
also
increasingli
report
due
similar
polioviru
enteroviru
known
caus
acut
flaccid
paralysi
strongli
suspect
caus
paralysi
infect
patient
possibl
remain
investig
septemb
number
pediatr
patient
present
cough
wheez
suddenli
increas
tokyo
metropolitan
children
medic
center
japan
number
patient
alloc
diagnosi
procedur
combin
dpc
code
wheez
asthma
treatment
doubl
fig
although
outbreak
observ
japan
infecti
pathogen
suspect
caus
respiratori
symptom
possibl
etiolog
agent
includ
immedi
activ
surveil
implement
prospect
collect
respiratori
sampl
made
order
identifi
pathogen
hospit
patient
five
sampl
obtain
earli
stage
investig
sent
laboratori
test
sever
virus
includ
determin
whether
investig
sampl
patient
warrant
sentinel
test
four
five
sampl
posit
revers
transcriptionpolymeras
chain
reaction
rtpcr
aim
studi
therefor
compar
pcrposit
pcrneg
patient
regard
clinic
manifest
surg
patient
respiratori
symptom
singlecent
outbreak
investig
conduct
septemb
octob
tokyo
metropolitan
children
medic
center
bed
japan
studi
prospect
design
predefin
inclus
exclus
criteria
respect
studi
implement
patient
characterist
clinic
inform
collect
retrospect
patient
admit
divis
gener
pediatr
given
written
document
contain
requir
element
inform
consent
ask
guardian
allow
physician
collect
util
anonym
clinic
data
research
futur
give
guardian
opportun
suffici
time
opt
provid
permiss
admit
hospit
consent
form
research
enrol
obtain
guardian
inclus
criteria
hospit
respiratori
symptom
inform
consent
guardian
sampl
collect
molecular
analysi
demograph
clinic
inform
includ
length
hospit
collect
electron
medic
record
respiratori
symptom
defin
cough
rhinorrhea
wheez
hypoxia
without
cardiac
etiolog
axillari
temperatur
defin
fever
nasopharyng
swab
test
multiplex
respiratori
viru
pcr
rtpcr
sampl
obtain
routin
test
pcr
virus
mycoplasma
test
select
case
dna
rna
extract
nasopharyng
swab
process
use
qiaamp
minelut
viru
spin
kit
qiagen
hilden
germani
rtpcr
perform
tokyo
metropolitan
children
medic
center
amplif
use
commerci
multiplex
viru
pcr
assay
scyme
bunkyo
tokyo
japan
follow
virus
respiratori
syncyti
virus
rsv
b
influenza
virus
b
human
metapneumoviru
human
bocaviru
adenoviru
rhinoviru
cytomegaloviru
coronaviru
mycoplasma
pneumonia
test
use
loopmedi
isotherm
amplif
method
eiken
chemic
tokyo
japan
physician
charg
consid
potenti
etiolog
pathogen
base
patient
age
symptom
regardless
patient
elig
studi
realtim
rtpcr
perform
nation
institut
infecti
diseas
tokyo
sequenc
analysi
partial
viral
structur
protein
vp
region
perform
sever
realtim
rtpcr
posit
sampl
partial
region
amplifi
clinic
sampl
seminest
rtpcr
phylogenet
tree
gener
use
neighborjoin
method
base
partial
sequenc
nucleotid
length
four
strain
studi
access
number
ddbj
databas
strain
repres
clade
subclad
strain
blood
sampl
collect
physician
thought
procedur
appropri
regardless
whether
patient
elig
studi
consolid
groundglass
opac
hyperluc
lung
air
trap
chest
xray
defin
abnorm
chest
xray
check
interpret
pediatr
radiologist
patient
posit
pcr
compar
control
group
patient
neg
pcr
continu
variabl
describ
median
iqr
analyz
use
wilcoxon
ranksum
test
nomin
variabl
describ
n
analyz
use
pearson
chisquar
test
fisher
exact
test
determin
signific
group
pcrposit
patient
associ
explanatori
variabl
sever
analyz
use
univari
logist
regress
sever
defin
presenc
either
intens
care
unit
icu
admiss
use
magnesium
sulfat
noninvas
posit
pressur
mechan
ventil
hospit
durat
treat
binari
variabl
classifi
accord
median
univari
analysi
twosid
pvalu
use
analys
statist
analys
perform
use
stata
statist
softwar
releas
statacorp
colleg
station
tx
usa
institut
review
board
grant
approv
studi
studi
period
hospit
patient
elig
enrol
nasopharyng
swab
obtain
patient
fig
one
sampl
taken
tracheostomi
tube
detect
sampl
number
posit
sampl
peak
midseptemb
fig
three
children
requir
admiss
pediatr
intens
care
unit
picu
case
acut
flaccid
paralysi
mortal
encount
studi
cohort
phylogenet
analysi
sever
strain
studi
cohort
clade
b
identifi
strain
mainli
detect
part
asia
usa
fig
tabl
list
particip
characterist
symptom
durat
onset
symptom
time
sampl
p
well
onset
symptom
admiss
p
significantli
shorter
pcrposit
group
blood
cultur
neg
test
patient
viral
coinfect
detect
rsv
type
b
human
metapneumoviru
human
rhinoviru
adenoviru
cytomegaloviru
human
coronaviru
tabl
mycoplasma
pneumonia
test
five
patient
consid
plausibl
etiolog
agent
depend
patient
age
clinic
manifest
detect
three
patient
neg
pcr
two
sputum
cultur
sampl
obtain
intub
patient
tracheostomi
patient
grew
methicillinresist
staphylococcu
aureu
pseudomona
aeruginosa
consid
pathogen
colon
tabl
list
potenti
univari
predictor
posit
children
hospit
previou
histori
asthma
univari
analysi
howev
histori
asthma
hospit
icu
prolong
hospit
determin
sever
statist
signific
previous
suggest
predictor
includ
age
sex
prematur
also
predict
sever
infect
defin
presenc
either
icu
admiss
use
magnesium
sulfat
noninvas
posit
pressur
mechan
ventil
studi
encount
outbreak
autumn
septemberoctob
number
patient
respiratori
symptom
requir
treatment
wheez
increas
dramat
compar
previou
year
similar
increas
report
sever
locat
throughout
japan
period
follow
first
report
nationwid
outbreak
subsequ
confirm
enteroviru
gener
endem
temper
zone
occur
frequent
summer
caus
handfootmouth
diseas
herpangina
asept
mening
interestingli
show
distinct
season
prefer
judg
increas
report
late
summer
autumn
global
outbreak
north
america
europ
report
case
august
decemb
japan
well
major
outbreak
peak
autumn
reason
season
circul
often
occur
later
typic
ev
outbreak
remain
unknown
except
report
australia
detect
winterspr
month
julyoctob
although
one
articl
suggest
endem
circul
taiwan
whether
endem
japan
global
remain
clarifi
present
studi
durat
onset
symptom
admiss
sampl
shorter
pcrposit
group
neg
group
two
possibl
explan
first
pcrposit
group
may
experienc
rapid
progress
symptom
requir
earlier
hospit
pcrneg
group
second
although
patient
pcrneg
group
may
infect
patient
slow
progress
symptom
could
sampl
later
clinic
cours
result
viral
load
undetect
pcr
acut
flaccid
myeliti
patient
pcr
detect
rate
higher
sampl
perform
day
onset
compar
overal
rate
percentag
patient
requir
intens
treatment
picu
admiss
supplement
oxygen
iv
magnesium
sulfat
significantli
differ
neg
group
ev
gener
caus
sever
ill
young
infant
viral
sepsi
asept
mening
enceph
myocard
unlik
ev
typic
affect
older
children
asthmalik
bold
p
percentag
calcul
base
total
number
exclud
miss
valu
characterist
fisher
exact
test
wilcoxon
ranksum
test
posit
mycoplasma
pneumonia
loopmedi
isotherm
amplif
cultureconfirm
invas
bacteri
infect
n
consolid
ground
glass
opac
hyperluc
lung
due
air
trap
crp
creactiv
protein
cvd
cardiovascular
diseas
enteroviru
loh
length
hospit
nmd
neuromuscular
diseas
nippv
noninvas
posit
pressur
ventil
pcr
polymeras
chain
reaction
picu
pediatr
intens
care
unit
wbc
white
blood
cell
respiratori
diseas
present
find
also
line
previou
report
usa
outbreak
median
age
year
group
rel
higher
age
distribut
seen
common
infecti
agent
rsv
regard
host
factor
histori
asthma
report
risk
factor
sever
respiratori
diseas
present
studi
infect
histori
asthma
associ
either
sever
defin
icu
admiss
magnesium
sulfat
use
ventil
support
prolong
hospit
none
three
patient
pcr
posit
admit
icu
histori
asthma
one
patient
histori
milk
allergi
chromosom
abnorm
contrast
one
three
patient
pcr
neg
admit
icu
histori
asthma
preterm
deliveri
although
result
line
previou
report
present
retrospect
design
might
meant
thorough
histori
take
possibl
note
reliabl
valid
asthma
diagnosi
like
differ
across
differ
studi
one
studi
netherland
compar
three
method
name
selfreport
asthma
diagnosi
hospit
registri
data
antiasthmat
medic
use
prescript
registri
explor
preval
asthma
examin
agreement
differ
method
found
substanti
non
overlap
method
regard
asthma
preval
anoth
articl
report
depend
parent
report
might
result
underestim
preval
seriou
asthma
especi
among
poor
children
usa
suggest
differ
method
produc
differ
preval
asthma
even
cohort
children
therefor
plausibl
would
happen
across
differ
cohort
moreov
diagnosi
asthma
earli
childhood
may
accur
due
frequenc
viral
infect
resembl
asthmat
symptom
short
whether
presenc
asthma
influenc
sever
respiratori
infect
requir
research
phylogenet
analysi
present
studi
report
japan
strain
identifi
genet
clade
b
usa
respiratori
infect
suspect
connect
case
pediatr
acut
flaccid
paralysismyel
although
encount
case
acut
flaccid
paralysismyel
present
studi
sever
case
acut
flaccid
myeliti
follow
confirm
infect
report
japan
nation
activ
symptombas
surveil
acut
flaccid
myeliti
conduct
august
decemb
japan
identifi
case
although
detect
cerebrospin
fluid
specimen
one
adult
patient
signific
tempor
correl
acut
flaccid
myeliti
epidem
curv
number
detect
note
nation
pathogen
surveil
present
studi
number
limit
first
although
collect
inform
patient
defin
respiratori
symptom
admit
studi
period
abl
recruit
obtain
sampl
multiplex
pcr
hospit
patient
patient
shortterm
admiss
discharg
provid
inform
consent
sampl
low
recruit
rate
could
bias
result
miss
mild
case
potenti
select
bia
howev
less
like
distort
result
one
includ
physician
investig
patient
knew
case
statu
time
recruit
second
sever
respiratori
pathogen
parainfluenza
viru
bordetella
pertussi
test
studi
might
miss
third
mild
case
infect
might
overlook
one
inclus
criteria
hospit
restrict
recruit
patient
admit
preclud
us
obtain
sampl
patient
visit
outpati
ward
result
could
infer
degre
associ
symptom
patient
wheez
symptom
sever
enough
requir
hospit
period
although
observ
surg
patient
wheez
unpreced
fig
phenomenon
observ
nation
fourth
pcrneg
group
patient
infect
might
miss
pcr
due
long
interv
sampl
symptom
onset
center
diseas
control
prevent
recommend
collect
sampl
day
symptom
onset
realtim
pcr
detect
nonpolio
enteroviru
addit
accord
nationwid
surveil
usa
respiratori
specimen
collect
day
respiratori
illnessfev
onset
compar
time
higher
detect
rate
vs
thu
addit
analys
chose
day
cutoff
point
onset
symptom
found
statist
signific
differ
posit
patient
whose
sampl
collect
day
onset
day
p
fisher
exact
test
nonetheless
find
signific
differ
baselin
clinic
characterist
conclud
misclassif
substanti
bias
result
tabl
final
might
remain
potenti
misclassif
stem
fact
group
could
contain
patient
viral
infect
asthma
attack
due
noninfecti
caus
thu
conduct
addit
analysi
divid
group
two
group
neg
posit
multiplex
rtpcr
neg
multiplex
rtpcr
compar
baselin
clinic
characterist
three
group
name
pcr
posit
group
pcr
neg
posit
multiplex
rtpcr
neg
multiplex
rtpcr
confirm
signific
differ
result
tabl
addit
analysi
furthermor
may
reason
potenti
misclassif
regard
diseas
statu
among
group
like
nondifferenti
multiplex
pcr
faster
sensit
viral
detect
tradit
viral
cultur
method
conclus
half
sampl
children
admit
respiratori
symptom
posit
pcr
surg
number
patient
respiratori
symptom
contrast
previou
research
asthma
histori
associ
risk
develop
sever
respiratori
infect
present
studi
